Income Taxes (Details Narrative) - USD ($)	3 Months Ended
	Jun. 30, 2015	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Deferred tax asset		$ 11,379,317
Net operating loss carry forwards		33,468,578
Amount of NOL acuired in reverse aquisition fo BMSG		38,616
Amount of NOL attributable to Bio-Matrix Scientific Group, Inc.		$ 33,429,962
Federal Corporate income tax Rate	34.00%